No significant differences in mRNA or nuclear and cytoplasmic NF-κB levels appeared among the STZ-T1DM model rats or STZ-T1DM + ESA + brusatol-treated rats (Figure 2A–C). The gene discussed is NFKB1; the disease is type 1 diabetes mellitus.